Medical Technologies
Non Communicable Disease (NCD) negotiations
Blogs and articles by KEI
- April 22, 2011. Six NGOs present recommendations for Moscow WHO forum on non-communicable diseases. http://keionline.org/node/1118
- September 10, 2011. Krista Cox, Obama Administration Wants to Eliminate References to Doha Declaration in UN Political Declaration on Non-Communicable Diseases. KeiOnline.Org, http://www.keionline.org/node/1252
Cable titled: RUSSIA RISES AS MAJOR CENTER FOR CLINICAL DRUG TRIALS
September 8, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
On August 1, 2008, then Deputy Chief of Mission in the Moscow Embassy Eric Rubin sent a cable that looked at the medical clinical trials industry in Russia.
These are a few of the highlights:
Cable details "textbook case of how not to conduct a public vaccination campaign" in Romania by Merck and GSK
September 6, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
A high profile campaign to promote the HPV vaccine for cervical cancer in Romania was described by Embassy officials as a failure, and a " textbook case of how not to conduct a public vaccination campaign." Among other things, the campaign featured a Merck sponsored visit by former Secretary of State Madeleine Albright. Here are some highlights from the cable:
2009 January 14 cable on Poland pharmaceutical reimbursement list
This is one of several Wikileaks cables on Poland pharmaceutical reimbursements.
Some highlights from this cable:
- Pfizer's head of government affairs estimated it contains about 10 new molecules without generic competitors. Meaningful access to the Polish market often hinges on a drug appearing on the list, since those drugs are subsidized by the National Health Fund (NFZ) and doctors most often prescribe drugs from the list.
2006 Cable: US, UK, French, German and Danish officials lobby against Polish price cuts for pharmaceutical drugs
September 3, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
This July 3, 2006 cable discusses a U.S. mobilization to oppose a reduction in pharmaceutical prices in Poland. The cable notes that
2,446 Wikileaks cables mentioning the search term "pharmaceutical"
The following are 2,446 cables from Wikileaks, that mention the search term: "pharmaceutical." The search was conducted on August 29, 2011. This is an average of 23 cables per week, for the period. The cables are organized by dates.
- 05/07/01 Nigeria Embassy Abuja Oau Hiv/aids Summit In Abuja
- 10/23/01 Nigeria Embassy Abuja Nigeria: Trips And Access To Medicines
John LaMattian, former head of Pfizer R&D, says industry mergers have harmed R&D efforts
Submitted by James Love on 23. August 2011 - 14:06John L. LaMattina, the former President of Pfizer Global Research and Development, has just published an article in Nature that looks at the impact of drug company mergers and increased industry concentration on R&D. Among his conclusions: the "impact on the R&D of the organizations involved has been devastating."
http://www.nature.com/nrd/journal/v10/n8/full/nrd3514.html
COMMENT
NATURE REVIEWS | DRUG DISCOVERY VOLUME 10 | AUGUST 2011 | 559
The impact of mergers on pharmaceutical R&D
ADAP Financial Eligibility Criteria and ADAP Expenditures
Submitted by Krista Cox on 22. August 2011 - 10:46AIDS Drug Assistance Programs (ADAP) serve low-income, underinsured or uninsured HIV-positive patients in the United States and its territories. General eligibility requirements may include residency, clinical eligibility based on specific CD4 counts, and income. Specific eligibility criteria for each ADAP is determined by each individual state.
ADAP waiting lists continue to grow; 9,217 individuals on waiting lists, 64% are African American or Hispanic
Submitted by Krista Cox on 16. August 2011 - 14:16The number of patients sitting on AIDS Drug Assistance Programs (ADAP) wait lists, denied the life-saving treatment they need, have risen dramatically over the past two years. ADAPs are critical in providing HIV/AIDS treatment to low-income, uninsured, or underinsured patients within the United States and its territories. As noted in an earlier KEI blog, in January 2010, 361 individuals were on ADAP waitlists; that number grew to 7,873 across eleven states as of May 5, 2011 (a 2100% increase over less than sixteen months).